• 1. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 2. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 3. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 4. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 5. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220

Recent Advances in the Application of Cbz-NH-PEG2-CH2COOH (CAS: 165454-06-8) in Chemical Biology and Pharmaceutical Research

The compound Cbz-NH-PEG2-CH2COOH (CAS: 165454-06-8) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications in drug discovery, bioconjugation, and targeted delivery systems. This research brief aims to provide an overview of the latest advancements and findings related to this compound, highlighting its potential in various therapeutic and diagnostic applications.

Cbz-NH-PEG2-CH2COOH is a carbobenzyloxy (Cbz)-protected amine-terminated polyethylene glycol (PEG) linker with a carboxylic acid functional group. The PEG spacer (PEG2) enhances solubility and reduces immunogenicity, making it an ideal candidate for bioconjugation strategies. Recent studies have explored its utility in the synthesis of peptide-drug conjugates (PDCs) and antibody-drug conjugates (ADCs), where it serves as a stable and biocompatible linker.

One of the most notable applications of Cbz-NH-PEG2-CH2COOH is in the development of targeted cancer therapies. Researchers have utilized this compound to conjugate cytotoxic agents to tumor-specific antibodies or peptides, enabling selective delivery to cancer cells while minimizing off-target effects. A 2023 study published in the Journal of Medicinal Chemistry demonstrated the efficacy of a Cbz-NH-PEG2-CH2COOH-linked ADC in preclinical models of breast cancer, showing significant tumor regression with reduced systemic toxicity.

In addition to its role in drug delivery, Cbz-NH-PEG2-CH2COOH has been employed in the development of novel imaging agents. A recent study in Bioconjugate Chemistry reported the synthesis of a fluorescent probe using this linker, which exhibited high stability and specificity for tumor-associated antigens. This innovation holds promise for improving the accuracy of cancer diagnostics and monitoring therapeutic responses in real-time.

Beyond oncology, Cbz-NH-PEG2-CH2COOH has found applications in the field of neurodegenerative diseases. Researchers have leveraged its bioconjugation capabilities to develop peptide-based therapeutics for Alzheimer's and Parkinson's diseases. A 2022 study in ACS Chemical Neuroscience highlighted the use of this linker to enhance the blood-brain barrier penetration of neuroprotective peptides, offering a potential breakthrough in the treatment of these debilitating conditions.

The chemical stability and biocompatibility of Cbz-NH-PEG2-CH2COOH have also made it a valuable tool in proteomics and chemical biology. Its ability to form stable amide bonds with primary amines has facilitated the development of novel probes for protein labeling and interaction studies. Recent advancements in mass spectrometry-based proteomics have utilized this linker to identify and quantify protein-protein interactions with high precision.

Despite its many advantages, challenges remain in the optimization of Cbz-NH-PEG2-CH2COOH-based conjugates. Issues such as linker stability in vivo, conjugation efficiency, and scalability of synthesis are areas of active research. A 2023 review in Advanced Drug Delivery Reviews emphasized the need for further studies to address these limitations and unlock the full potential of this versatile compound.

In conclusion, Cbz-NH-PEG2-CH2COOH (CAS: 165454-06-8) represents a powerful tool in modern chemical biology and pharmaceutical research. Its applications span drug delivery, diagnostics, and proteomics, with ongoing studies continually expanding its utility. As research progresses, this compound is poised to play an increasingly critical role in the development of next-generation therapeutics and diagnostic tools.

• 77109-84-3(2-methoxyethyl N-[(benzyloxy)carbonyl]glycinate)
• 205535-92-8((2-[2-(2-hydroxy-ethoxy)-ethoxy]-ethyl)-carbamic acid benzyl ester)
• 206265-31-8(5,8,11-Trioxa-2-azatridecanoic acid, 13-hydroxy-, phenylmethyl ester)
• 4816-85-7
• 33350-33-3(Carbamic acid, ethyl-, 2-[[(phenylmethoxy)carbonyl]amino]ethyl ester)
• 169744-02-9(Carbamic acid, [2-[2-(2-aminoethoxy)ethoxy]ethyl]-, phenylmethyl ester)
• 77109-85-4(Glycine, N-[(phenylmethoxy)carbonyl]-, 2-ethoxy-2-oxoethyl ester)
• 30751-61-2(Carbamic acid, [2-(acetyloxy)ethyl]-, phenylmethyl ester)
• 145881-74-9(benzyl N-[2-(2-hydroxyethoxy)ethyl]carbamate)
• 462100-05-6(Cbz-NH-PEG3-CH2COOH)